Latest Articles

Publication Date
The Great Masquerader: Accessory Cavitating Uterine Mass (ACUM). Evaluation, diagnosis, and surgical management.

Accessory cavitating uterine masses (ACUM) are rare, cystic uterine anomalies associated with an otherwise normal uterus and reproductive tract. They are diagnosed via a presence of a noncommunicating accessory cavity …

Published: Nov. 26, 2025, midnight
Urine and Serum miRNA Signatures for the Non-Invasive Diagnosis of Adenomyosis: A Machine Learning-Based Pilot Study.

Background: Adenomyosis remains difficult to diagnose non-invasively due to clinical overlap with endometriosis and the limited specificity of imaging techniques. This pilot study evaluated whether serum- and urine-derived microRNA (miRNA) …

Published: Nov. 26, 2025, midnight
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Beaver County Times

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Beaver County Times

Published: Nov. 25, 2025, 9:18 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Central New Jersey News

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Central New Jersey News

Published: Nov. 25, 2025, 8:33 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - The Herald-Mail

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis The Herald-Mail

Published: Nov. 25, 2025, 6:12 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Akron Beacon Journal

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Akron Beacon Journal

Published: Nov. 25, 2025, 5:16 p.m.
EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis - Markets Financial Content

EndoDiagnosis Announces CReATe Fertility as First Canadian Clinic to Offer Tier 1 ENDOSURE Diagnostic Test for Endometriosis Markets Financial Content

Published: Nov. 25, 2025, 12:42 a.m.
Identifying serum microRNAs as biomarkers for endometriosis in adolescents and young adults.

Endometriosis is a gynecological disorder that affects 190 million reproductive age women worldwide. Laparoscopic surgery is considered the gold standard to diagnose the disease, creating a barrier to diagnosis and …

Published: Nov. 24, 2025, midnight
Mesonephric-like Adenocarcinoma (MLA) Diagnostic Criteria and Controversies: Perspectives and Guidance From Pathologists in the MLA Consortium.

Mesonephric-like adenocarcinoma (MLA) is a rare and aggressive gynecologic malignancy that has only been recognized in the last decade. It arises in the endometrium, ovaries, and other extrauterine sites (often …

Published: Nov. 24, 2025, midnight
Diagnostic accuracy of non-coding RNA for detecting endometriosis: A systematic review and meta-analysis.

Endometriosis diagnosis currently relies on invasive laparoscopy, creating a need for non-invasive alternatives. This study evaluates microRNAs (miRNAs) as potential diagnostic biomarkers for endometriosis through systematic evidence synthesis and performance …

Published: Nov. 24, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!